For the quarter ending 2025-09-30, PTPI made $1,056,751 in revenue. -$1,153,933 in net income. Net profit margin of -109.20%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Cost of goods sold | - | - | 298,292.5 | 287,005 |
| Net sales | - | - | 1,057,103 | 1,576,366 |
| Gross profit | - | - | 758,810.5 | 1,289,361 |
| Depreciation and amortization expense | - | - | 686,966 | 739,449 |
| Research and development expense | - | - | 828,948.5 | 588,355 |
| Intangible asset impairment | - | - | 741,690 | - |
| Api asset impairment | - | - | 2,950,121 | - |
| Selling, general and administrative | 990,737 | 1,800,778 | 2,080,583.5 | 2,301,305 |
| Total operating expenses | 990,737 | 1,800,778 | 7,288,309 | 3,629,109 |
| Loss from continuing operations | -990,737 | -1,800,778 | -6,529,498.5 | -2,339,748 |
| Interest expense, promissory note | - | - | 140,227.25 | - |
| Change in fair value of derivative liability | - | - | 867,000 | 202,000 |
| Change in fair value of warrant liability | -1,000 | 329,343 | - | - |
| Interest income | 67,014 | 88,849 | 88,280.5 | 75,817 |
| Amount of the cost of promissory notes accounted for as interest expense for debt | - | - | - | 158,730 |
| Total other income, net | 68,014 | -240,494 | 811,447 | 119,087 |
| Loss before income taxes | -922,723 | -2,041,272 | -5,718,051.5 | -2,220,661 |
| Loss from continuing operations, net of tax | -922,723 | -2,041,272 | - | - |
| Gain (loss) from discontinued operations | - | 500,816 | - | - |
| Gain from assignment of subsidiaries and vivus settlement | - | 6,973,302 | - | - |
| Net income (loss) | -922,723 | 5,432,846 | -5,718,051.5 | -2,220,661 |
| Preferred stock dividend and cash premiums | 231,210 | - | 519,814.5 | 1,051,695 |
| Preferred stock accretion | - | - | 3,169,896.5 | 1,974,359 |
| Net loss attributable to common stockholders | - | - | -9,407,762.5 | -5,246,715 |
| Net loss from continuing operations attributable to common stockholders | -1,153,933 | - | - | - |
| Earnings per share, basic | -0.03 | -1.29 | -1.22 | -0.53 |
| Earnings per share, diluted | -0.03 | -1.29 | -1.22 | -0.53 |
| Weighted average number of shares outstanding, basic | 42,284,502 | 25,922,503 | -4,595,931 | 9,829,793 |
| Weighted average number of shares outstanding, diluted | 42,284,502 | 25,922,503 | -4,595,931 | 9,829,793 |
Petros Pharmaceuticals, Inc. (PTPI)
Petros Pharmaceuticals, Inc. (PTPI)